Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate ; volume:14 ; number:1 ; day:14 ; month:1 ; year:2016 ; pages:1-8 ; date:12.2016
BMC medicine ; 14, Heft 1 (14.1.2016), 1-8, 12.2016
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-016-0550-5
- URN
-
urn:nbn:de:101:1-2019070519315754954531
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hobbs, FD Richard
- Banach, Maciej
- Mikhailidis, Dimitri P.
- Malhotra, Aseem
- Capewell, Simon
- SpringerLink (Online service)
Other Objects (12)
Debate: Should statin be used in patients with heart failure?
Dynamic patterns of blood lipids and DNA methylation in response to statin therapy
Lipids
Debate on HES safety is important, but must be based on facts
The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome
Chromosomal and gonadal sex drive sex differences in lipids and hepatic gene expression in response to hypercholesterolemia and statin treatment
Statin Intolerance: Diagnosis and Management
Genetic determinants of statin intolerance
Pazopanib and Statin-Induced Rhabdomyolysis
Lipids and Lipidoses
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
Debate: Should statin be used in patients with heart failure?
Dynamic patterns of blood lipids and DNA methylation in response to statin therapy
Lipids
Debate on HES safety is important, but must be based on facts
The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome
Chromosomal and gonadal sex drive sex differences in lipids and hepatic gene expression in response to hypercholesterolemia and statin treatment
Statin Intolerance: Diagnosis and Management
Genetic determinants of statin intolerance
Pazopanib and Statin-Induced Rhabdomyolysis
Lipids and Lipidoses
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
Debate: Should statin be used in patients with heart failure?
Dynamic patterns of blood lipids and DNA methylation in response to statin therapy
Lipids
Debate on HES safety is important, but must be based on facts
The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome
Chromosomal and gonadal sex drive sex differences in lipids and hepatic gene expression in response to hypercholesterolemia and statin treatment
Statin Intolerance: Diagnosis and Management
Genetic determinants of statin intolerance
Pazopanib and Statin-Induced Rhabdomyolysis
Lipids and Lipidoses
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection